阿昔莫司在降低脂蛋白a 方面的临床研究
摘要
关键词
全文:
PDF参考
[1]Cannon, C. P. et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes[J]. The New England journal
of medicine 372, 2387–2397(2015).
[2]Ellis, K. L., Boffa, M. B., Sahebkar, A., Koschinsky, M. L. & Watts, G. F. The renaissance of lipoprotein(a): Brave new
world for preventive cardiology[J]. Progress in Lipid Research 68, 57–82(2017).
[3]Pirro, M. et al. Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity[J]. Pharma -
cological Research 119, 178–187(2017).
[4]Marcovina, S. M., & Albers, J. J. (2015). Lipoprotein (a) measurements for clinical application[J]. Journal of Lipid
Research, 57(4), 526–537.
[5]Schmidt, K., Noureen, A., Kronenberg, F. & Utermann, G. Stru cture, function, and genetics of lipoprotein (a)[J]. J Lip -
id Res 57, 1339–1359(2016).
[6]Thomas, T. et al. CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of
Lipoprotein(a) in Mildly Hypercholesterolemic Subjects[J]. Arteriosclerosis, thrombosis, and vascular biology 37, 1770–
1775(2017).
[7]Sharma, M., Redpath, G. M., Williams, M. J. & McCormick, S. P. Recycling of Apolipoprotein(a) After PlgRKT-Mediated
Endocytosis of Lipoprotein(a)[J]. Circulation research 120, 1091–1102(2017).
[8]Tie, C. et al. Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition[J].
PLoS One 10, e0142430(2015).
[9]Qin, L. et al. Anti-inflammatory activity of ezetimibe by re gulating NF-kappaB/MAPK pathway in THP-1 macrophages[
J]. Pharmacology 93, 69–75(2014).
[10]Dolezelova, E. et al. Effect of ezetimibe on plasma adipoki nes: a systematic review and meta-analysis[J]. Br J Clin
Pharmacol 83,1380–1396(2017).
[11]Tsimikas, S. A Test in Context: Lipoprotein(a)[J]. Journal of the American College of Cardiology, 69(6), 692–
711(2017).
DOI: http://dx.doi.org/10.18686/xyfyx.v2i2.26935
Refbacks
- 当前没有refback。